When HER2+ LM3 and TNBC E0771 mouse tumors reached a burden of 500 mm3, the vector was delivered once every three days for a total of three treatments, leading to tumor growth delay and decreased lung metastases. This evidence concerns the gene ERBB2 and neoplasm.